San Diego, CA, United States of America

Kimberlee Fischer

USPTO Granted Patents = 6 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Kimberlee Fischer: Innovator in Immunoconjugates

Introduction

Kimberlee Fischer is a prominent inventor based in San Diego, CA, known for her significant contributions to the field of immunoconjugates. With a total of six patents to her name, she has made remarkable strides in developing innovative methods for targeted drug delivery, particularly in cancer treatment.

Latest Patents

Fischer's latest patents focus on immunoconjugates that include a linking group for connecting an antibody targeting ligand (Ab) to a drug (D). These immunoconjugates are designed to deliver drugs to specific cells or tissues, enhancing the efficacy of cancer treatments. The formula for these immunoconjugates is represented as Ab-[S-L-L-L-L-L-L-L-D], showcasing her innovative approach to drug delivery systems.

Career Highlights

Throughout her career, Kimberlee Fischer has worked with notable companies such as Immunome, Inc. and Zeno Management, Inc. Her experience in these organizations has allowed her to refine her expertise in immunology and drug development, contributing to her success as an inventor.

Collaborations

Fischer has collaborated with talented individuals in her field, including Xiaojun Han and Suvi Tuula Marjukka Orr. These partnerships have fostered a collaborative environment that encourages innovation and the advancement of medical technologies.

Conclusion

Kimberlee Fischer's work in immunoconjugates exemplifies her dedication to improving cancer treatment through innovative drug delivery methods. Her contributions to the field are significant and continue to inspire future advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…